These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525 [TBL] [Abstract][Full Text] [Related]
6. Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials. Galli M; Andreotti F; D'Amario D; Porto I; Crea F J Am Coll Cardiol; 2020 Apr; 75(14):1727-1728. PubMed ID: 32273039 [No Abstract] [Full Text] [Related]
7. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease. Cairns JA; McMurtry MS Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600 [TBL] [Abstract][Full Text] [Related]
8. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial. Gong X; Hua R; Bai J; Wu T; Wang Q; Zhang J; Zhang W; Ying L; Ke Y; Wang X; Zhang X; Liu K; Chen Y; Zhang B; Dong P; Xiao J; Li C; Zhu L; Li C Clin Cardiol; 2023 Jul; 46(7):777-784. PubMed ID: 37191146 [TBL] [Abstract][Full Text] [Related]
10. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting. Pipilis A; Lazaros G; Tsakonas G; Stefanadis C Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831 [No Abstract] [Full Text] [Related]
11. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy? Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. Lane DA; Dagres N; Dan GA; García Seara J; Iliodromitis K; Lenarczyk R; Lip GYH; Mansourati J; Marín F; Scherr D; Potpara TS Europace; 2019 Jul; 21(7):1116-1125. PubMed ID: 30874724 [TBL] [Abstract][Full Text] [Related]
15. Is There a Role for Triple Therapy After ACS? Bhogal S; Alkhouli M; White CJ; Bailey S; Mamas M; Haddad E; Paul TK Curr Cardiol Rep; 2022 Mar; 24(3):191-200. PubMed ID: 35112242 [TBL] [Abstract][Full Text] [Related]
16. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS. Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444 [TBL] [Abstract][Full Text] [Related]
17. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Mishra A; Singh M; Acker WW; Kamboj S; Sporn D; Stapleton D; Kaluski E J Cardiovasc Pharmacol; 2019 Aug; 74(2):82-90. PubMed ID: 31306367 [TBL] [Abstract][Full Text] [Related]
18. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839 [TBL] [Abstract][Full Text] [Related]
19. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930 [TBL] [Abstract][Full Text] [Related]
20. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Douketis JD; Spyropoulos AC; Spencer FA; Mayr M; Jaffer AK; Eckman MH; Dunn AS; Kunz R Chest; 2012 Feb; 141(2 Suppl):e326S-e350S. PubMed ID: 22315266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]